首屆診所細胞治療品質認證結果初探

Results of the First Cell Therapy Clinic Quality Certification: A Preliminary Study

隨著全球再生醫療蓬勃發展，細胞治療技術發展日新月異且逐漸成熟，於癌症、心血管疾病治療、皮膚修復等疾病提出新的醫療方式，財團法人醫院評鑑暨醫療品質策進會（以下簡稱醫策會）醫策會自2021年推動及辦理診所細胞治療品質認證作業，協助政府提升國內整體細胞治療執行品質，以確保病人安全及提升診所之醫療服務品質。

本研究分析2021年參與「診所細胞治療品質認證」的13家診所之成績及意見內容，以提供其他有意願參與認證之診所參考。研究結果顯示診所尚須強化之處，主要包含人員教育訓練計畫之訂定、儀器設備管理、病歷記載及急救流程等方面。建議診所可透過定期案例討論及、依循認證查核項目內容，提升人員對於相關風險之警覺性與認知度，並建議衛福部及醫策會持續辦理認證，為民眾就醫安全把關，以及衛生主管機關可加強向民眾宣導應選擇有取得政府核准的醫療機構就醫，以維護病人安全。

 

With the rapid advances in regenerative medicine worldwide, cell therapy technology has gradually matured and generated new treatment methods for conditions such as cancer, cardiovascular diseases, and skin repair. In Taiwan, the Joint Commission of Taiwan has been promoting and organizing clinic cell therapy quality certification since 2021, assisting the government in improving the quality of cell therapy to ensure patient safety and enhance the quality of clinic medical services.

This study analyzed the performance and feedback of 13 clinics participating in a Cell Therapy Clinic Quality Certification project in 2021, and the findings are expected to be of reference value to clinics intending to commit themselves to the certification. The results indicated that clinics must improve their staff training plans, equipment management, medical record management, and first aid processes. Clinics are advised to improve staff alertness and awareness of relevant risks by organizing periodic case discussions and reviewing items required for the certification. The Ministry of Health and Welfare and the Joint Commission of Taiwan are advised to retain the certification system, thereby safeguarding the public’s medical safety. Moreover, competent health authorities are advised to actively advocate the importance of selecting medical institutions with government-approved certificates to ensure patient safety.